Aside Archives

Inter-Ministerial Cooperation for Promotion and Facilitation of Agricultural Biotechnology Research and Education

Signing of Memorandum of Understanding (MoU) between
Indian Council of Agricultural Research & Department of Biotechnology, Govt. of India

New Delhi, January 14, 2019. The Department of Biotechnology (DBT) has undertaken several activities and programs to promote Biotechnology Research & Development in the areas of Agriculture Biotechnology. The Indian Council of Agricultural Research (ICAR) has been coordinating, guiding and managing research and education in Agriculture including horticulture, fisheries and animal sciences in the entire country. In order to leverage the efforts, the DBT and ICAR has entered into Memorandum of Understanding (MoU) for much-needed emphasis on multi-disciplinary R&D activities and nurturing innovations in Agricultural Biotechnology Research and Education.

About the MoU

The MoU between ICAR and DBT is for mutual collaboration to explore the possibility of cooperation, convergence and synergy to promote and accelerate the progress of research and training in various disciplines of agricultural biotechnology between ICAR and DBT.

The MoU will be implemented with the aim to collaborate with one another in mutually agreed-upon research programmes in the areas of agricultural biotechnology, funding of projects, policy issues, regulatory aspects, and other specified areas of National interest. The specific objectives are to plan and implement jointly the mutually agreed major National programmes through joint funding and sharing of resources in the priorities areas of agricultural biotechnology; to form common think tank of experts from ICAR and DBT and others to formulate policies; to establish National platform/centres for services related to genomics, genotyping, data banking, agriculture bioinformatics, GM food detection, validation of technologies such as vaccines, diagnostics of veterinary/ fisheries use, molecular markers in crop and animal breeding; to formulate and introduce courses/training programmes in the area of IPR, biosafety, biodiversity conservation and germ plasm exchange, genomic selection and breeding for faculty and students through appropriate mechanisms and; research prioritization with other ministries and foreign collation like Indo-UK SIC, BRICS, African countries and ‘Look East’ programme in relation to agricultural biotechnology.

Secretary, DBT highlighted the importance of the MOU through which five to ten focused programmes both short term, medium and long term will be developed and implemented. The major facilities and technology platforms created by both the agencies will be accessible to the National systems. A joint working group to be constituted to take the partnership forward. The collaborations also encompass to promote agri-innovations and start-ups, through the well established BIRAC mechanism. This flagship synergistic approach would be taken-up in mission mode through networking with the elite institutions in the Country.

Memorandum of Understanding (MoU) between
ICAR & DBT

SAHAJ

The Department of Biotechnology announces the Access of it’s Research Resources and Facilities supported across the country, by way of Scientific Infrastructure Access for Harnessing Academia University Research Joint Collaboration, (SAHAJ). Each DBT Autonomous Institute and DBT supported Infrastructure programme will make available its high end equipments and infrastructure to Research Institutes, Universities, Colleges and Start -ups /Entrepreneurs. Their website shall reflect Infrastructure facility usage forms with well defined usage charges terms and conditions.

The details of the application procedure can be accessed at the respective websites of the Institutes hosting these facilities.

Scientific Infrastructure Access for Harnessing Academia University Research joint Collaboration(SAHAJ)

New Delhi, December 31, 2018. India is a repertoire for traditional systems of medicine and has met primary health care needs of millions. However, for globalization of such rich traditional knowledge base, well-researched indigenous natural products have to be manufactured using best practices. In order to leverage the efforts, the Ministry of AYUSH and Department of Biotechnology (DBT), Ministry of Science & Technology has entered into Memorandum of Understanding (MoU) for inter-ministerial cooperation. The focus is on boosting innovative research on biotechnological intervention in AYUSH sector.

About the MoU

The MoU between Ministry of AYUSH and DBT is for mutual collaboration to explore the possibility of cooperation, convergence and synergy to have a biotechnological intervention in AYUSH sector and to have a platform for exchange of information between both the Ministry of AYUSH and DBT.

The role of each party has been defined in the MoU. DBT will be responsible for undertaking the research on domestication, identification of elite and quality planting material of selected medicinal and aromatic plants and their mass multiplication etc. The Ecological Niche modelling developed by DBT on RET (rare, endangered and threatened) species of medicinal importance will be used by National Medicinal Plant Board (NMPB), Ministry of AYUSH in conservation, augmentation, development and cultivation promotion of medicinal plants. DBT would undertake R&D projects to validate AYUSH concepts and medicines and would play a major role in supply chain management of medicinal plants by developing technological intervention and DBT and NMPB can develop collaboration in implementation of DBT’s initiatives on Phytopharmaceutical Mission in North East Region. Ministry of AYUSH will help and guide DBT in taking already available research leads forward towards developing drugs in AYUSH mode.

.

This flagship synergistic approach would be taken-up in mission mode through networking with the elite institutions in the Country.

Press Release Ministry of AYUSH & Department of Biotechnology (DBT)

New Delhi, December 31, 2018. India is known for its traditional systems of medicine for health care. The resource base to support delivery through such a system has been developed systematically over the years and is continuously being strengthened and positioned to attract the global attention. For the centuries,India has also been at theforefront forthe use of medicinal and aromatic plants.

The Gazette of India notification of guidelines for phytopharmaceutical drug development offers opportunity to leverage traditional knowledge for drug development based on modern science and modern medicine principles.

In order to leverage the effort, the Council of Scientific & Industrial Research (CSIR), Department of Biotechnology (DBT) and Indian Council of Medical Research (ICMR) have entered into Memorandum of Understanding (MoU) for inter-ministerial cooperation.The focus is on boosting innovative research on phytopharmaceuticals.

About the MoU

The MoU amongst CSIR, DBT and ICMR is for mutual collaboration to develop phytopharmaceutical products for therapeutic use following international standards and norms for establishing safety, quality, standardization and efficacy. The effort would beto take forward the leads already existing with CSIR, DBT and ICMR and develop specific collaborative projects in the domain aiming at rigorous modern scientific testing and development of standard products to maintain global competitiveness.

The role of each agency has been defined in the MoU. CSIR will be responsible for undertaking the R&D for developing desired phytopharmaceutical leads (both with short term & long term translational period), which can be taken forward for positioned product development following DCGI regulatory guidelines; pre-clinical pharmacology; CMC and IND enabling studies; and safety and regulatory toxicity studies. DBT would be responsible for identifying the leads based on its extra-mural research, providing funds for R&D projects taken under the MoU and preparation of respective sections of IND dossier in mutual collaboration with ICMR. Preparation of IND dossier and its submission to DCGI, preparation of clinical trials protocols, obtaining regulatory clearance for clinical trials and conducting trials with compilation of results etc. would be the responsibility of ICMR.

This synergetic approach being put in the country for the first time would lead to taking up of the identified activities in the mission mode through best of the institutions in the Country. The CSIR had launched “Phytopharmaceutical Mission” about a year back

Secretary, DSIR & DG, CSIR and Secretary, DHR; Secretary, DBT; & DG, ICMR during the signing ceremony of the MoU

Secretary, DSIR & DG, CSIR and Secretary, DHR; Secretary, DBT; & DG, ICMR during the signing ceremony of the MoU